Jarislowsky Fraser LTD Upped By $339,651 Its Chevron (CVX) Holding; Matarin Capital Management Has Lifted Five Prime Therapeutics (FPRX) Position By $567,900

June 2, 2017 - By Adrian Mccoy

Jarislowsky Fraser Ltd increased Chevron Corporation (CVX) stake by 0.41% reported in 2016Q4 SEC filing. Jarislowsky Fraser Ltd acquired 2,903 shares as Chevron Corporation (CVX)’s stock declined 3.45%. The Jarislowsky Fraser Ltd holds 718,207 shares with $84.53M value, up from 715,304 last quarter. Chevron Corporation now has $196.92B valuation. The stock declined 1.07% or $1.12 reaching $103.15 on the news. About 3.04 million shares traded. Chevron Corporation (NYSE:CVX) has risen 6.68% since June 2, 2016 and is uptrending. It has underperformed by 10.02% the S&P500.

Matarin Capital Management Llc increased Five Prime Therapeutics Inc. (FPRX) stake by 9.68% reported in 2016Q4 SEC filing. Matarin Capital Management Llc acquired 11,358 shares as Five Prime Therapeutics Inc. (FPRX)’s stock declined 39.09%. The Matarin Capital Management Llc holds 128,661 shares with $6.45 million value, up from 117,303 last quarter. Five Prime Therapeutics Inc. now has $843.43 million valuation. The stock rose 1.00% or $0.29 reaching $29.3 per share. About 152,600 shares traded. Five Prime Therapeutics Inc (NASDAQ:FPRX) has declined 30.56% since June 2, 2016 and is downtrending. It has underperformed by 47.26% the S&P500.

Since December 8, 2016, it had 0 insider purchases, and 3 insider sales for $19.97 million activity. Breber Pierre R had sold 45,000 shares worth $5.03M on Thursday, February 2. WATSON JOHN S had sold 125,000 shares worth $13.79M on Monday, March 13.

Investors sentiment decreased to 0.99 in 2016 Q4. Its down 0.08, from 1.07 in 2016Q3. It fall, as 55 investors sold CVX shares while 689 reduced holdings. 120 funds opened positions while 617 raised stakes. 1.17 billion shares or 3.12% more from 1.13 billion shares in 2016Q3 were reported. State Of New Jersey Common Pension Fund D accumulated 775,000 shares. Dupont Capital accumulated 114,725 shares. Coho Limited invested 2.32% of its portfolio in Chevron Corporation (NYSE:CVX). Asset Management reported 33,539 shares. Moreover, Wealthtrust has 0.05% invested in Chevron Corporation (NYSE:CVX). Skba Capital Limited Liability reported 3.03% stake. 158 are owned by Commonwealth Limited Liability Corp. Segall Bryant Hamill Ltd Limited Liability Company has invested 0.18% in Chevron Corporation (NYSE:CVX). Los Angeles Cap Mngmt Equity Rech stated it has 445,619 shares. Burke Herbert State Bank Co holds 23,598 shares. Eqis Cap Mngmt Inc, a California-based fund reported 6,905 shares. Marshall Wace Llp reported 12,258 shares. Adell Harriman And Carpenter reported 28,360 shares stake. Papp L Roy Assocs owns 94,661 shares or 2.55% of their US portfolio. 64,547 were reported by Bank & Trust Inc.

Jarislowsky Fraser Ltd decreased Emerson Electric Co. (NYSE:EMR) stake by 22,952 shares to 601,087 valued at $33.51 million in 2016Q4. It also reduced Banco Santander Sa Adr (NYSE:SAN) stake by 116,109 shares and now owns 551,299 shares. Exxon Mobil Corporation (NYSE:XOM) was reduced too.

Among 31 analysts covering Chevron Corporation (NYSE:CVX), 21 have Buy rating, 1 Sell and 9 Hold. Therefore 68% are positive. Chevron Corporation had 60 analyst reports since August 4, 2015 according to SRatingsIntel. Morgan Stanley upgraded the stock to “Overweight” rating in Tuesday, November 1 report. The firm has “Buy” rating given on Thursday, December 1 by Independent Research. On Monday, August 3 the stock rating was maintained by UBS with “Neutral”. Barclays Capital maintained the shares of CVX in report on Monday, October 12 with “Equal-Weight” rating. The stock has “Outperform” rating by Wolfe Research on Wednesday, March 9. The firm has “Buy” rating given on Tuesday, November 3 by Evercore. As per Monday, October 31, the company rating was upgraded by Goldman Sachs. The company was upgraded on Wednesday, December 2 by Citigroup. CLSA upgraded Chevron Corporation (NYSE:CVX) on Tuesday, November 15 to “Buy” rating. The firm earned “Buy” rating on Wednesday, December 16 by Argus Research.

Since December 23, 2016, it had 0 insider purchases, and 4 insider sales for $1.73 million activity. Another trade for 500 shares valued at $23,085 was sold by RINGO WILLIAM R. Sarena Francis Willard also sold $172,310 worth of Five Prime Therapeutics Inc (NASDAQ:FPRX) on Wednesday, January 18. Williams Lewis T also sold $1.51 million worth of Five Prime Therapeutics Inc (NASDAQ:FPRX) shares.

Among 7 analysts covering Five Prime Therapeutics (NASDAQ:FPRX), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Five Prime Therapeutics had 11 analyst reports since July 31, 2015 according to SRatingsIntel. As per Thursday, January 21, the company rating was initiated by Credit Suisse. Wells Fargo maintained Five Prime Therapeutics Inc (NASDAQ:FPRX) on Friday, December 4 with “Outperform” rating. The rating was initiated by Citigroup with “Buy” on Tuesday, October 25. The firm earned “Outperform” rating on Friday, March 11 by Credit Suisse. As per Friday, July 31, the company rating was initiated by Citigroup. The rating was maintained by Oppenheimer with “Outperform” on Monday, October 19. The rating was upgraded by Zacks on Tuesday, August 11 to “Sell”. BMO Capital Markets initiated the stock with “Market Perform” rating in Tuesday, April 12 report. Zacks upgraded Five Prime Therapeutics Inc (NASDAQ:FPRX) on Friday, August 21 to “Sell” rating.

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.41, from 1.15 in 2016Q3. It is negative, as 19 investors sold FPRX shares while 69 reduced holdings. 16 funds opened positions while 49 raised stakes. 24.63 million shares or 4.67% less from 25.83 million shares in 2016Q3 were reported. Matarin Cap Mgmt Llc has 0% invested in Five Prime Therapeutics Inc (NASDAQ:FPRX). Strs Ohio owns 19,900 shares or 0% of their US portfolio. Assetmark Incorporated reported 0% stake. Panagora Asset holds 11,782 shares. Sterling Cap Limited Liability Company holds 0.01% or 18,678 shares. Awm Investment holds 0.79% or 80,000 shares in its portfolio. Oakworth Cap Incorporated holds 207 shares. Schwab Charles Investment reported 205,556 shares. Fred Alger Mgmt reported 15,000 shares. Alliancebernstein Limited Partnership accumulated 89,550 shares. Blackrock Fund Advsr invested in 1.22M shares or 0.01% of the stock. Shell Asset Mngmt reported 0.02% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Credit Suisse Ag owns 76,053 shares. Victory Capital Management Inc holds 0.06% or 475,383 shares in its portfolio. New York State Common Retirement Fund holds 0% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX) for 39,400 shares.